Results 71 to 80 of about 57,360 (167)

Effects of Hypoglycemic Agents on The Musculoskeletal System: A Comprehensive Review. [PDF]

Drug Des Devel Ther
Zhao J, Lv SS, Lu Q, Cong XX, Zhang XF.
europepmc   +1 more source

Comparison of efficacy and safety of three novel hypoglycemic agents in patients with severe diabetic kidney disease: A systematic review and network meta-analysis of randomized controlled trials. [PDF]

Front Endocrinol (Lausanne), 2022
Li Y, Hu Y, Huyan X, Chen K, Li B, Gu W, Mu Y.   +6 more
europepmc   +1 more source

Recent progress on the development of hydrogel‐based microneedles for transdermal drug delivery

VIEW, EarlyView.
This study provides a comprehensive and up‐to‐date analysis of recent progress in HMN technology, covering fundamental transdermal delivery mechanisms and design principles, biomaterials used in HMN fabrication, drug loading and release strategies, and emerging therapeutic applications.
Mohammad Muhtasim Ittisaf, Salman Farsi Taharat, Md. Sadek Miah, Hasan Tasnim Salehin, M. Azam Ali, Shoeb Ahmed   +5 more
wiley   +1 more source

Caffeoylquinic Acids From Lonicera japonica Thunb. as Hypoglycemic Agents: Network Pharmacology and Pharmacological Validation. [PDF]

J Diabetes Res
Ye Y, Xu D, Zhang S, Yu H, Liu Y, Yang J, Sun L.   +6 more
europepmc   +1 more source

Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes： A Network Meta-Analysis. [PDF]

Front Endocrinol (Lausanne), 2021
Lian J, Fu J.
europepmc   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Comparative Analysis of Potential Side Effects of Targeted Oral Hypoglycemic Agents Using Spontaneous Adverse Event Reports and Social Media Data. [PDF]

Pharmacoepidemiol Drug Saf
Oh SH, Park DY, Song YK.
europepmc   +1 more source

Continuity and Completeness of Electronic Health Record Data for Patients Treated With Oral Hypoglycemic Agents: Findings From Healthcare Delivery Systems in Taiwan. [PDF]

Front Pharmacol, 2022
Hsu CN, Huang K, Lin FJ, Ou HT, Huang LY, Kuo HC, Wang CC, Toh S.   +7 more
europepmc   +1 more source

Narrative Review on Therapies That Influence Inflammatory Responses During Extremely Premature Perinatal Respiratory Transition

Acta Paediatrica, EarlyView.
ABSTRACT Aims and Methods Advances in neonatal care have extended borderline survival to 22–24 post‐conceptional weeks. Present review discusses approaches for prolonging short pregnancies and prevention of serious morbidities in extremely premature infants born before 28 weeks of pregnancy.
Mikko Hallman
wiley   +1 more source

Hypoglycemic agents and contrast-induced acute kidney injury in type 2 diabetes: A retrospective cohort study of patients undergoing coronary angiography or percutaneous coronary intervention. [PDF]

Sci Prog
Guo D, Du X, Zhang T, Liu R, Ma M.
europepmc   +1 more source